Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
28,736,767
-
Number of holders
-
264
-
Total 13F shares, excl. options
-
30,100,794
-
Shares change
-
-1,454,825
-
Total reported value, excl. options
-
$3,243,258,025
-
Value change
-
-$145,765,701
-
Put/Call ratio
-
140%
-
Number of buys
-
150
-
Number of sells
-
-111
-
Price
-
$107.74
Significant Holders of GeneDx Holdings Corp. - Common Stock (WGS) as of Q3 2025
322 filings reported holding WGS - GeneDx Holdings Corp. - Common Stock as of Q3 2025.
GeneDx Holdings Corp. - Common Stock (WGS) has 264 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 30,100,794 shares
.
Largest 10 shareholders include Corvex Management LP (3,058,629 shares), Casdin Capital, LLC (3,007,164 shares), BlackRock, Inc. (1,529,075 shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (1,220,138 shares), VANGUARD GROUP INC (1,170,422 shares), GOLDMAN SACHS GROUP INC (1,168,180 shares), ORACLE INVESTMENT MANAGEMENT INC (889,954 shares), SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC (823,567 shares), T. Rowe Price Investment Management, Inc. (718,003 shares), and FRANKLIN RESOURCES INC (681,381 shares).
This table shows the top 264 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.